Metabolic syndrome-mediated inflammation following elective percutaneous coronary intervention

Steven P. Marso, Joseph W. Murphy, John A. House, David M. Safley, William Harris

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

There are few data concerning the relationship between diabetes mellitus, the metabolic syndrome and inflammation following elective percutaneous coronary intervention (PCI). The purpose of this study was to assess basal and peak levels of candidate cytokines in 40 patients undergoing elective PCI. Patients were categorised as having diabetes mellitus, the metabolic syndrome, or neither. Patients with the metabolic syndrome exhibited significantly greater levels of tumour necrosis factor-α over the study period, although this was unrelated to PCI. There was a trend for increased levels of interleukin-6 following PCI, primarily among patients with metabolic syndrome. Basal levels of monocyte chemoattractant protein-1 (MCP-1) were not different among study groups; however, the metabolic syndrome cohort had a trend towards increased circulating levels of MCP-1 after PCI. In this patient population, the metabolic syndrome correlates with a heightened inflammatory response following elective PCI.

Original languageEnglish (US)
Pages (from-to)31-36
Number of pages6
JournalDiabetes and Vascular Disease Research
Volume2
Issue number1
StatePublished - Feb 2005
Externally publishedYes

Fingerprint

Percutaneous Coronary Intervention
Inflammation
Chemokine CCL2
Diabetes Mellitus
Interleukin-6
Tumor Necrosis Factor-alpha
Cytokines
Population

Keywords

  • Diabetes mellitus
  • Inflammation
  • Metabolic syndrome
  • Percutaneous coronary intervention
  • Restenosis

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Cardiology and Cardiovascular Medicine

Cite this

Marso, S. P., Murphy, J. W., House, J. A., Safley, D. M., & Harris, W. (2005). Metabolic syndrome-mediated inflammation following elective percutaneous coronary intervention. Diabetes and Vascular Disease Research, 2(1), 31-36.

Metabolic syndrome-mediated inflammation following elective percutaneous coronary intervention. / Marso, Steven P.; Murphy, Joseph W.; House, John A.; Safley, David M.; Harris, William.

In: Diabetes and Vascular Disease Research, Vol. 2, No. 1, 02.2005, p. 31-36.

Research output: Contribution to journalArticle

Marso, SP, Murphy, JW, House, JA, Safley, DM & Harris, W 2005, 'Metabolic syndrome-mediated inflammation following elective percutaneous coronary intervention', Diabetes and Vascular Disease Research, vol. 2, no. 1, pp. 31-36.
Marso, Steven P. ; Murphy, Joseph W. ; House, John A. ; Safley, David M. ; Harris, William. / Metabolic syndrome-mediated inflammation following elective percutaneous coronary intervention. In: Diabetes and Vascular Disease Research. 2005 ; Vol. 2, No. 1. pp. 31-36.
@article{a038fb2d749b4fda88e569edb6574b56,
title = "Metabolic syndrome-mediated inflammation following elective percutaneous coronary intervention",
abstract = "There are few data concerning the relationship between diabetes mellitus, the metabolic syndrome and inflammation following elective percutaneous coronary intervention (PCI). The purpose of this study was to assess basal and peak levels of candidate cytokines in 40 patients undergoing elective PCI. Patients were categorised as having diabetes mellitus, the metabolic syndrome, or neither. Patients with the metabolic syndrome exhibited significantly greater levels of tumour necrosis factor-α over the study period, although this was unrelated to PCI. There was a trend for increased levels of interleukin-6 following PCI, primarily among patients with metabolic syndrome. Basal levels of monocyte chemoattractant protein-1 (MCP-1) were not different among study groups; however, the metabolic syndrome cohort had a trend towards increased circulating levels of MCP-1 after PCI. In this patient population, the metabolic syndrome correlates with a heightened inflammatory response following elective PCI.",
keywords = "Diabetes mellitus, Inflammation, Metabolic syndrome, Percutaneous coronary intervention, Restenosis",
author = "Marso, {Steven P.} and Murphy, {Joseph W.} and House, {John A.} and Safley, {David M.} and William Harris",
year = "2005",
month = "2",
language = "English (US)",
volume = "2",
pages = "31--36",
journal = "Diabetes and Vascular Disease Research",
issn = "1479-1641",
publisher = "SAGE Publications Ltd",
number = "1",

}

TY - JOUR

T1 - Metabolic syndrome-mediated inflammation following elective percutaneous coronary intervention

AU - Marso, Steven P.

AU - Murphy, Joseph W.

AU - House, John A.

AU - Safley, David M.

AU - Harris, William

PY - 2005/2

Y1 - 2005/2

N2 - There are few data concerning the relationship between diabetes mellitus, the metabolic syndrome and inflammation following elective percutaneous coronary intervention (PCI). The purpose of this study was to assess basal and peak levels of candidate cytokines in 40 patients undergoing elective PCI. Patients were categorised as having diabetes mellitus, the metabolic syndrome, or neither. Patients with the metabolic syndrome exhibited significantly greater levels of tumour necrosis factor-α over the study period, although this was unrelated to PCI. There was a trend for increased levels of interleukin-6 following PCI, primarily among patients with metabolic syndrome. Basal levels of monocyte chemoattractant protein-1 (MCP-1) were not different among study groups; however, the metabolic syndrome cohort had a trend towards increased circulating levels of MCP-1 after PCI. In this patient population, the metabolic syndrome correlates with a heightened inflammatory response following elective PCI.

AB - There are few data concerning the relationship between diabetes mellitus, the metabolic syndrome and inflammation following elective percutaneous coronary intervention (PCI). The purpose of this study was to assess basal and peak levels of candidate cytokines in 40 patients undergoing elective PCI. Patients were categorised as having diabetes mellitus, the metabolic syndrome, or neither. Patients with the metabolic syndrome exhibited significantly greater levels of tumour necrosis factor-α over the study period, although this was unrelated to PCI. There was a trend for increased levels of interleukin-6 following PCI, primarily among patients with metabolic syndrome. Basal levels of monocyte chemoattractant protein-1 (MCP-1) were not different among study groups; however, the metabolic syndrome cohort had a trend towards increased circulating levels of MCP-1 after PCI. In this patient population, the metabolic syndrome correlates with a heightened inflammatory response following elective PCI.

KW - Diabetes mellitus

KW - Inflammation

KW - Metabolic syndrome

KW - Percutaneous coronary intervention

KW - Restenosis

UR - http://www.scopus.com/inward/record.url?scp=14744293202&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14744293202&partnerID=8YFLogxK

M3 - Article

C2 - 16305070

AN - SCOPUS:14744293202

VL - 2

SP - 31

EP - 36

JO - Diabetes and Vascular Disease Research

JF - Diabetes and Vascular Disease Research

SN - 1479-1641

IS - 1

ER -